{
  "docId": "019de077-0285-7666-8a7c-e862967898bc",
  "docSlug": "fea13a4d561ba57c72ad56a940de546b",
  "documentTitle": "Evotec | Investor Presentation Deck | 49 slides",
  "authorId": "evotec",
  "authorName": "Evotec",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 49,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "comparison_table",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 3,
  "notes": "The slide uses a process-flow comparison to illustrate the shift from 1x dose to 10,000x doses.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-0285-7666-8a7c-e862967898bc/21",
  "deckHref": "/decks/019de077-0285-7666-8a7c-e862967898bc",
  "deckJsonHref": "/decks/019de077-0285-7666-8a7c-e862967898bc.json",
  "deckAnchorHref": "/decks/019de077-0285-7666-8a7c-e862967898bc#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.67,
        "y": 0.22
      },
      "kind": "list",
      "text": "iPSC-based off-the-shelf therapeutics benefits: Reduced complexity, unlimited material, versatile editing, consistent quality, on-demand availability, broad applicability.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3794d6dd-7277-4422-97af-fdf17772b26e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.6,
        "x": 0.03,
        "y": 0.2
      },
      "kind": "table",
      "text": "Comparison of Autologous, Allogeneic donor-derived, and Allogeneic iPSC-derived manufacturing processes.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c2c27b6-572d-459d-a3e6-3351c5bc6269",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.18,
        "y": 0.05
      },
      "kind": "title",
      "text": "Off-the-shelf approach will revolutionise cell therapy applications",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b1c8c50e-72bb-4ef5-903c-4d35b8b85fd7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.18,
        "y": 0.1
      },
      "kind": "title",
      "text": "Benefit of manufacturing process for iPSC-based therapeutics",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b1a1646f-a003-42a4-ac79-6a246f8009c7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Comparison frame",
      "slug": "comparison-frame",
      "agent": null,
      "layer": "slide",
      "matchId": "7f5beffd-a90b-4d4d-836b-43e4237c7d59",
      "evidence": "table/data: Comparison of Autologous, Allogeneic donor-derived, and Allogeneic iPSC-derived manufacturing processes.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "comparison-frame",
      "slug": null,
      "matchId": "31cc1bff-8c6c-44bf-a978-7fc96eddda37",
      "evidence": "The slide compares three distinct manufacturing models side-by-side to highlight the superiority of the iPSC-derived approach.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 49,
      "from": 17,
      "beatId": "f8e500c2-a0e1-44fd-9184-3e9083983bf3",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "Call to action for investors and next steps",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 28,
      "from": 17,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "443f578a-8001-4541-ab44-14a6fb00a964",
      "evidence": "Highlighting success stories and market potential",
      "position": 1,
      "objective": "Presenting Evotec's growth potential",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}